BUP.PA - Biom'Up S.A.

Paris - Paris Delayed price. Currency in EUR
+0.25 (+2.78%)
At close: 5:35PM CEST
Stock chart is not supported by your current browser
Previous close9.00
Bid0.00 x 0
Ask0.00 x 0
Day's range9.10 - 9.35
52-week range8.47 - 13.89
Avg. volume8,548
Market cap117.217M
PE ratio (TTM)N/A
EPS (TTM)-3.21
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est14.75
  • GlobeNewswire19 hours ago

    Biom’up Has Trained 200 Surgeons in its International KOL-Led Program Ahead of HEMOBLAST Bellows™ Launch

    NEW YORK and SAINT-PRIEST, France, April 24, 2018 (GLOBE NEWSWIRE) -- Biom'up (BUP.PA), a specialist in surgical hemostasis, today announced that its intensive training program to train surgeons in the use of its lead product HEMOBLAST Bellows is on track and has reached the Company’s objective of 200 trained surgeons ahead of the launch of HEMOBLAST Bellows in mid-2018. To prepare the surgical community for the imminent launch of HEMOBLAST Bellows, Biom’up ran 6 highly attended training sessions for surgeons in the U.S. and Europe, which were led by the Company’s experts in collaboration with key opinion leaders in surgical hemostasis.

  • GlobeNewswire9 days ago

    Biom'up reports 2017 full-year results and provides corporate update

    2017 results underscore focus on establishing a strong financial foundation as basis for commercial strategy going forward A total of €100 million raised through 2017 to date Marketing approval lead product ...

  • GlobeNewswire29 days ago

    Biom’up Appoints Thierry Darnis as Global Vice President, Manufacturing & Engineering

    SAINT-PRIEST, France, March 26, 2018-- Biom’ up, specialist of surgical hemostasis, today announced the appointment, effective May 2, 2018, of Thierry Darnis as Global Vice President Manufacturing and ...